Navigation Links
Penn Study finds virtual colonoscopy is used appropriately, may expand screening to more patients

PHILADELPHIA In 2009, the Centers for Medicare and Medicaid Services (CMS) halted reimbursement for so-called "virtual colonoscopy" for routine colon-cancer screening in asymptomatic patients, in part due to concerns over how this procedure, computed tomography colonography (CTC), was being used in the elderly population. In the first study to examine appropriate utilization of the test among asymptomatic Medicare beneficiaries from 2007 to 2008, a research team from the Perelman School of Medicine at the University of Pennsylvania found that CTC was used appropriately and may have expanded colorectal cancer screening beyond the population screened with standard ("optical") colonoscopy. The findings, led by Hanna M. Zafar, MD, MHS, an assistant professor of Radiology, are published online in the Journal of General Internal Medicine.

CTC is a minimally invasive method of visualizing the colon and rectum, which does not require sedation, unlike during standard colonoscopies. On average, CTC costs $400 to $800, and optical colonoscopy costs $1,500 to $3,000. However, patients with focal abnormalities on CTC (defined as suspected polyps greater than or equal to 6 mm and masses) must be referred to OC for direct tissue sampling.

The Penn Medicine research team examined records for 10,538 asymptomatic older patients who underwent CTC compared to 160,113 similar patients who underwent optical colonoscopy. They found that the vast majority of patients who received CTC had presumed incomplete optical colonoscopies and thus were considered appropriate candidates for the virtual screening method. Furthermore, almost half of the patients studied who underwent CTC following incomplete optical colonoscopy did so on the same day as optical colonoscopy. "Given that bowel preparation is a strong barrier to screening, offering same day CTC could improve completion of screening by eliminating the need for an additional bowel preparation," said Zafar. "As such, it is reassuring that CTC following incomplete optical colonoscopy is covered by most insurance companies and CMS."

Additionally, 30 percent of the patients who underwent CTC had no history of incomplete OC but demonstrated other medically appropriate indications for screening CTC including risk of bleeding or sedation complications. Although the researchers were not able to assess through the claims data studied how many of these patients would not have been screened without the option of CTC, it does suggest that during the study period, this test may have expanded colorectal cancer screening as opposed to simply replacing optical colonoscopy. (Prior research has shown that nearly 30 percent of patients would not undergo optical colonoscopy if CTC were not available.) "Additional research is needed in this important area since approximately 40 to 50 percent of Medicare patients do not undergo any recommended method of colon cancer screening," Zafar said.

The Penn Medicine study also found lower utilization of CTC among asymptomatic non-white patients. It is not clear whether this decreased utilization is due to overall lower rates of colorectal cancer screening in this group of patients, patient preference, or diminished access to imaging technology. But previous findings indicate that minority populations are less likely to be aware of colorectal cancer screening procedures and more likely to believe that screening is only needed after symptoms develop -- both represent barriers to colorectal cancer screening compliance. "Given the higher incidence and mortality from colorectal cancer among black patients and lower rates of screening in minority patients overall, this cohort could benefit most through CTC," said Zafar.

Colorectal cancer was the third most commonly diagnosed cancer among men and women, as well as the third leading cause of cancer death for 2012 in the United States. Although it is largely preventable through colonoscopy, screening remains underutilized. In light of their findings, the study team suggests that reimbursement for screening CTC may increase overall screening rates in the elderly but could simultaneously exacerbate disparities in colorectal cancer screening.

CMS' decision to end reimbursements in 2009 was subsequently opposed by several groups such as the American Cancer Society and American College of Radiology, which both recognize CTC as a recommended screening procedure for Americans ages 65 years and older.


Contact: Steve Graff
University of Pennsylvania School of Medicine

Related medicine news :

1. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
2. Brisk Walking Equals Running for Heart Health: Study
3. Not all patients benefit equally from hip or knee replacement: Study finds
4. Study reveals that chemotherapy works in an unexpected way
5. Balding Men Could Face Higher Heart Risks, Study Finds
6. U.S. Spends More on Dementia Care Than Heart Disease or Cancer: Study
7. Prostate cancer treatment study changing the way doctors practice
8. Dementia costs top those for heart disease or cancer, study finds
9. Nutralife Hails New Study’s Findings on SAM-e, Giving Hope to Millions Seeking Joint Relief
10. Low Testosterone Linked to Later Arthritis in Study
11. Black Men Often Face Delays in Prostate Cancer Care: Study
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Scientists in Seattle and Vancouver compared ... patients with or without mesothelioma. Surviving Mesothelioma has just posted an article on the ... PhenoPath Laboratories in Seattle and the University of British Columbia found that certain genetic ...
(Date:10/13/2015)... ... October 13, 2015 , ... World Patent Marketing , a vertically ... melting invention that helps people in clearing snow away from the streets and driveways. ... at 3.8% per year," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:10/13/2015)... ... October 13, 2015 , ... With Fall weather approaching and holiday travel season ... Facebook Hair Styler Contest. , Enter to win! , How to Enter:, 1. ... Favorite Hair Style? , 3. Follow us on Instagram @thebeautyplace , 4. Share ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Just under three ... customers, eMarketing Concepts began a $1 promotion – effectively offering all of their services ... and within weeks the company was flooded with phone calls from interested buyers. As ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... from GyencoloGeneTM, the world’s first commercially-available next-generation sequencing laboratory test for bacterial ... of Gynecology and Obstetrics in Vancouver, BC, Canada. , In a ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... Center for Innovation announced today that Elizabeth ... th recipient of the CME Group Melamed-Arditti Innovation ... Theranos , to change health care from reactive to proactive, ... care. CME Group will present the award at the eighth ... Naples, Florida , on Tuesday, November 17. ...
(Date:10/12/2015)... PUNE, India , October 12, 2015 ... new market research report "Spirometer Market by Product (Hand-held, Table-top, ... (Hospital, Clinic, Homecare), Application, & Geography - Global Forecast to ... reach USD 858.6 Million by 2020, at a CAGR of ... data Tables and 128 F igures spread th ...
(Date:10/12/2015)... ) ... "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Industry Trends, Technologies, Participants, and Environment" ... ) has announced the addition of ... Companion Diagnostic Market to 2019 - Strategic ...
Breaking Medicine Technology: